Compare UGP & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | UGP | CAI |
|---|---|---|
| Founded | 1937 | 2008 |
| Country | Brazil | United States |
| Employees | N/A | 1846 |
| Industry | Oil/Gas Transmission | Medical Specialities |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 4.7B |
| IPO Year | 2001 | N/A |
| Metric | UGP | CAI |
|---|---|---|
| Price | $6.29 | $15.59 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 11 |
| Target Price | $5.37 | ★ $30.91 |
| AVG Volume (30 Days) | ★ 4.6M | 3.4M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.61% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $9.93 | $25.24 |
| Revenue Next Year | $3.25 | $22.32 |
| P/E Ratio | $9.99 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.00 | $14.19 |
| 52 Week High | $6.70 | $42.50 |
| Indicator | UGP | CAI |
|---|---|---|
| Relative Strength Index (RSI) | 64.42 | 38.87 |
| Support Level | $5.65 | $14.19 |
| Resistance Level | N/A | $19.83 |
| Average True Range (ATR) | 0.17 | 0.92 |
| MACD | 0.05 | -0.19 |
| Stochastic Oscillator | 65.18 | 14.63 |
Ultrapar Participacoes SA engages in the investment of its own capital in services, commercial, and industrial activities, through the subscription or acquisition of shares of other companies. The company's business segments include: i) Ultragaz distributes LPG in the segments: bulk, comprising condominiums, trade, services, industries, and agribusiness; and bottled, mainly comprising residential consumers. ii) Ipiranga, the majority revenue generating segment, engages in the distribution and sale of oil-related products to service stations that operate under the Ipiranga brand throughout Brazil. iii) Ultracargo operates in specialized liquid bulk storage solutions in the main logistics centers. iv) Hidrovias: operates in logistics solutions and waterway and multimodal infrastructure.
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.